![Campbell Wilson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Campbell Wilson
Directeur/Membre du Conseil chez
Pharmaceutical Licensing Group Ltd.
Profil
Campbell Wilson is currently a Director at Pharmaceutical Licensing Group Ltd. and a Director at Tarsis Technology Ltd. He previously worked as a Director-Executive Business Development at AstraZeneca PLC and as an Independent Non-Executive Director at Frontier IP Group Plc from 2014 to 2023.
Postes actifs de Campbell Wilson
| Sociétés | Poste | Début |
|---|---|---|
Pharmaceutical Licensing Group Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Campbell Wilson
| Sociétés | Poste | Fin |
|---|---|---|
| FRONTIER IP GROUP PLC | Directeur/Membre du Conseil | 21/04/2023 |
Tarsis Technology Ltd.
 Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Directeur/Membre du Conseil | 13/09/2022 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Frontier IP Group Plc
 Frontier IP Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the commercialization of intellectual property | Commercial Services |
Pharmaceutical Licensing Group Ltd. | |
Tarsis Technology Ltd.
Tarsis Technology Ltd. Packaged SoftwareTechnology Services Develops and commercializes technology that allows delivery of drugs using metal-organic frameworks | Technology Services |
